Taiwan · Delayed Price · Currency is TWD AP Biosciences Statistics
Total Valuation
AP Biosciences has a market cap or net worth of TWD 15.32 billion. The enterprise value is 14.11 billion.
| Market Cap | 15.32B |
| Enterprise Value | 14.11B |
Important Dates
The next estimated earnings date is Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AP Biosciences has 85.11 million shares outstanding. The number of shares has increased by 21.09% in one year.
| Current Share Class | 85.11M |
| Shares Outstanding | 85.11M |
| Shares Change (YoY) | +21.09% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 5.90% |
| Owned by Institutions (%) | 13.02% |
| Float | 45.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 11.45 |
| P/TBV Ratio | 11.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -31.53 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -36.91 |
Financial Position
The company has a current ratio of 18.55, with a Debt / Equity ratio of 0.05.
| Current Ratio | 18.55 |
| Quick Ratio | 18.49 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.16 |
| Interest Coverage | -309.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -32.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +262.54% in the last 52 weeks. The beta is 0.33, so AP Biosciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +262.54% |
| 50-Day Moving Average | 135.36 |
| 200-Day Moving Average | 91.72 |
| Relative Strength Index (RSI) | 63.73 |
| Average Volume (20 Days) | 1,187,802 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -458.33M |
| Pretax Income | -447.41M |
| Net Income | -447.41M |
| EBITDA | -446.74M |
| EBIT | -458.33M |
| Earnings Per Share (EPS) | -5.26 |
Balance Sheet
The company has 1.27 billion in cash and 62.38 million in debt, giving a net cash position of 1.21 billion or 14.24 per share.
| Cash & Cash Equivalents | 1.27B |
| Total Debt | 62.38M |
| Net Cash | 1.21B |
| Net Cash Per Share | 14.24 |
| Equity (Book Value) | 1.34B |
| Book Value Per Share | 15.72 |
| Working Capital | 1.25B |
Cash Flow
In the last 12 months, operating cash flow was -361.10 million and capital expenditures -21.11 million, giving a free cash flow of -382.21 million.
| Operating Cash Flow | -361.10M |
| Capital Expenditures | -21.11M |
| Free Cash Flow | -382.21M |
| FCF Per Share | -4.49 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AP Biosciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.09% |
| Shareholder Yield | -21.09% |
| Earnings Yield | -2.92% |
| FCF Yield | -2.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |